CGON Competitors & Alternatives
Compare CG Oncology, Inc. Common stock with similar stocks in the same industry
Biotechnology
CGON
Main Stock$70.36
Tradestie Score
59
Market Cap
$3.01B
Revenue Growth
19.8%
Analyst Upside
+28.3%
Top Competitors
231 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
MRUS
Merus N.V. Common Shares
|
$90.00
|
$7.14B | - | 55 | Compare |
|
CYTK
Cytokinetics Inc.
|
$86.49
|
$6.68B | - | 64 | Compare |
|
RYTM
Rhythm Pharmaceuticals, Inc. Common Stock
|
$114.17
|
$6.64B | - | 54 | Compare |
|
ABVX
Abivax SA American Depositary Shares
|
$144.65
|
$6.38B | - | 59 | Compare |
|
LEGN
Legend Biotech Corporation American Depositary Shares
|
$29.91
|
$6.03B | - | 51 | Compare |
|
CRSP
CRISPR Therapeutics AG
|
$60.08
|
$6.02B | - | 63 | Compare |
|
NUVL
Nuvalent, Inc. Class A Common Stock
|
$123.73
|
$5.95B | - | 61 | Compare |
|
AXSM
Axsome Therapeutics, Inc
|
$244.31
|
$5.92B | - | 55 | Compare |
|
TGTX
TG Therapeutics, Inc.
|
$53.31
|
$5.80B | 18.7 | 55 | Compare |
|
KRYS
Krystal Biotech, Inc. Common Stock
|
$375.07
|
$5.20B | 49.7 | 61 | Compare |
More CGON Analysis
Data updated: Jul 04, 2026 | Industry: Biotechnology (SIC 2836)
231 stocks in this industry